# Cogent Biosciences, Inc.: filings

COGT · Nasdaq · CIK 1622229 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cogt.md) · [Financials](/companies/cogt/financials.md) · [Filings](/companies/cogt/filings.md) · [Insiders](/companies/cogt/insiders.md)

## Reports and events: 156 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 216, 8-K 98, SC 13G/A 40, 3 28, 10-Q 26, SC 13G 26, SCHEDULE 13G/A 18, 424B5 15, S-8 13, CORRESP 12, UPLOAD 10, DEF 14A 9, 10-K 8, EFFECT 8, 144 7, DEFA14A 7, SC 13D/A 6, PRE 14A 5, S-3 5, ARS 4, D 4, PRER14A 4, SCHEDULE 13D/A 4, SCHEDULE 13G 4, FWP 3, 3/A 2, 4/A 2, CT ORDER 2, POS AM 2, S-3ASR 2, SEC STAFF LETTER 2, 10-Q/A 1, 424B3 1, 424B4 1, 8-A12B 1, 8-K/A 1, CERT 1, DEFM14A 1, DRS 1, DRS/A 1, DRSLTR 1, S-1 1, S-1/A 1, SC 13D 1, SC TO-I 1, SC TO-I/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-02 | 20:11 ET | [8-K](/filings/0001193125-26-380194.md) | 1.01 Entry into a material agreement | 0001193125-26-380194 |
| 2026-08-10 | 21:19 ET | [8-K](/filings/0001193125-26-342695.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-342695 |
| 2026-08-10 | 20:11 ET | [10-Q](/filings/0001193125-26-342393.md) | Quarterly report, period 2026-06-30 | 0001193125-26-342393 |
| 2026-08-10 | 12:06 ET | [8-K](/filings/0001193125-26-341315.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-341315 |
| 2026-06-11 | 20:15 ET | [8-K](/filings/0001193125-26-267566.md) | 5.07 Shareholder vote results | 0001193125-26-267566 |
| 2026-05-05 | 12:21 ET | [10-Q](/filings/0001193125-26-205170.md) | Quarterly report, period 2026-03-31 | 0001193125-26-205170 |
| 2026-05-05 | 12:08 ET | [8-K](/filings/0001193125-26-205124.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-205124 |
| 2026-04-23 | 20:30 ET | [DEF 14A](/filings/0001193125-26-173834.md) | Proxy statement, period 2026-06-09 | 0001193125-26-173834 |
| 2026-03-31 | 01:30 ET | [SCHEDULE 13D/A](/filings/0001104659-26-038056.md) | Ownership report, active investor, amended | 0001104659-26-038056 |
| 2026-02-17 | 14:24 ET | [10-K](/filings/0001193125-26-053334.md) | Annual report, period 2025-12-31 | 0001193125-26-053334 |
| 2026-02-17 | 13:12 ET | [8-K](/filings/0001193125-26-053131.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-053131 |
| 2026-01-22 | 01:02 ET | [SCHEDULE 13D/A](/filings/0001104659-26-005917.md) | Ownership report, active investor, amended | 0001104659-26-005917 |
| 2025-12-08 | 21:05 ET | [8-K](/filings/0001193125-25-311217.md) | 8.01 Other events | 0001193125-25-311217 |
| 2025-11-18 | 21:09 ET | [8-K](/filings/0001193125-25-286158.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-286158 |
| 2025-11-17 | 21:36 ET | [SCHEDULE 13D/A](/filings/0001104659-25-113219.md) | Ownership report, active investor, amended | 0001104659-25-113219 |
| 2025-11-13 | 11:05 ET | [8-K](/filings/0001193125-25-278679.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-278679 |
| 2025-11-10 | 13:01 ET | [8-K](/filings/0001193125-25-273315.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-273315 |
| 2025-11-07 | 21:08 ET | [10-Q](/filings/0001193125-25-272334.md) | Quarterly report, period 2025-09-30 | 0001193125-25-272334 |
| 2025-11-03 | 14:13 ET | [8-K](/filings/0001193125-25-261797.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-261797 |
| 2025-09-11 | 20:30 ET | [8-K](/filings/0001193125-25-201353.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-201353 |
| 2025-08-05 | 12:46 ET | [10-Q](/filings/0000950170-25-102440.md) | Quarterly report, period 2025-06-30 | 0000950170-25-102440 |
| 2025-08-05 | 12:41 ET | [8-K](/filings/0000950170-25-102433.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-102433 |
| 2025-07-14 | 20:31 ET | [SCHEDULE 13D/A](/filings/0001104659-25-067760.md) | Ownership report, active investor, amended | 0001104659-25-067760 |
| 2025-07-10 | 12:00 ET | [8-K](/filings/0001193125-25-157390.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-157390 |
| 2025-07-07 | 11:15 ET | [8-K](/filings/0001193125-25-155811.md) | 8.01 Other events | 0001193125-25-155811 |
| 2025-06-11 | 12:15 ET | [8-K](/filings/0001193125-25-138813.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-138813 |
| 2025-06-05 | 12:15 ET | [8-K](/filings/0001193125-25-135337.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-135337 |
| 2025-05-06 | 13:00 ET | [10-Q](/filings/0000950170-25-064005.md) | Quarterly report, period 2025-03-31 | 0000950170-25-064005 |
| 2025-05-06 | 12:19 ET | [8-K](/filings/0000950170-25-063987.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-063987 |
| 2025-04-22 | 20:31 ET | [DEF 14A](/filings/0001193125-25-089237.md) | Proxy statement, period 2025-06-04 | 0001193125-25-089237 |
| 2025-02-25 | 13:38 ET | [10-K](/filings/0000950170-25-026115.md) | Annual report, period 2024-12-31 | 0000950170-25-026115 |
| 2025-02-25 | 13:20 ET | [8-K](/filings/0000950170-25-026103.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-026103 |
| 2024-12-09 | 21:01 ET | [8-K](/filings/0001193125-24-273393.md) | 8.01 Other events | 0001193125-24-273393 |
| 2024-11-12 | 14:08 ET | [10-Q](/filings/0000950170-24-124712.md) | Quarterly report, period 2024-09-30 | 0000950170-24-124712 |
| 2024-11-12 | 13:28 ET | [8-K](/filings/0000950170-24-124653.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-124653 |
| 2024-09-03 | 12:15 ET | [8-K](/filings/0001193125-24-211584.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-211584 |
| 2024-08-06 | 12:40 ET | [10-Q](/filings/0000950170-24-091229.md) | Quarterly report, period 2024-06-30 | 0000950170-24-091229 |
| 2024-08-06 | 12:20 ET | [8-K](/filings/0000950170-24-091220.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-091220 |
| 2024-06-27 | 12:05 ET | [8-K](/filings/0001193125-24-169756.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-169756 |
| 2024-06-13 | 10:06 ET | [SC 13D/A](/filings/0001193125-24-160264.md) | Ownership report, active investor, amended | 0001193125-24-160264 |
| 2024-06-05 | 20:02 ET | [8-K](/filings/0001193125-24-155116.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-24-155116 |
| 2024-05-07 | 12:26 ET | [10-Q](/filings/0000950170-24-053977.md) | Quarterly report, period 2024-03-31 | 0000950170-24-053977 |
| 2024-05-07 | 12:19 ET | [8-K](/filings/0000950170-24-053974.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-053974 |
| 2024-04-23 | 20:32 ET | [DEF 14A](/filings/0001193125-24-107124.md) | Proxy statement, period 2024-06-05 | 0001193125-24-107124 |
| 2024-04-01 | 22:30 ET | [SC 13D/A](/filings/0001193125-24-083703.md) | Ownership report, active investor, amended | 0001193125-24-083703 |
| 2024-03-27 | 20:37 ET | [SC 13D/A](/filings/0001193125-24-078864.md) | Ownership report, active investor, amended | 0001193125-24-078864 |
| 2024-03-22 | 12:33 ET | [8-K](/filings/0001193125-24-074628.md) | 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-24-074628 |
| 2024-02-26 | 14:13 ET | [10-K](/filings/0000950170-24-019770.md) | Annual report, period 2023-12-31 | 0000950170-24-019770 |
| 2024-02-26 | 13:30 ET | [8-K](/filings/0000950170-24-019754.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-019754 |
| 2024-02-16 | 23:55 ET | [SC 13D/A](/filings/0001193125-24-038694.md) | Ownership report, active investor, amended | 0001193125-24-038694 |

Page 1 of 4. [Older](/companies/cogt/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.